Sign in
Taking people in United StatesNo phase

Wearable nerve-stimulation band for adults with long-lasting nausea and vomiting

Tests whether a wearable EmeTerm device eases nausea in adults with chronic nausea.

Key facts

Who runs it
Ohio State University
Where
Columbus, United StatesSee the site
Trial code
Registry title
Evaluating Whether a Nausea Band Reduces Symptoms in Those With Chronic Nausea Vomiting
Status
Recruiting
People taking part
120 people, planned
Started
1 Feb 2023
Expected to end
30 Jun 2028
Type of study
Interventional
Treatments tested
  • EmeTerm wearable TENS device
Record updated
22 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have had nausea for more than 2 months and get care at The Ohio State University. They will test a wrist-worn nerve stimulation device called EmeTerm.

Age
18 years or older
Sex
All sexes can join
Disease stage
Nausea present for more than 2 months. People must understand English and be able to fill in online surveys on a smartphone or computer.
Earlier treatment
People who have used a wearable TENS unit for nausea before cannot join.

Main reasons for not taking part

  • Current treatment for cancer or for inflammatory bowel disease
  • Cirrhosis or end-stage kidney disease
  • Pregnancy, abdominal surgery in the last 3 months, or a history of seizures
  • A pacemaker, implanted defibrillator, metal implants or other implanted electronic device
  • Skin problems near the wrist, current carpal tunnel syndrome, or a recent head injury, brain tumor, meningitis or stroke

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Nausea present for more than 2 months. Age 18 years or older. Able to understand English. Receiving care at The Ohio State University. Able to complete online surveys using a smartphone or computer

Who cannot take part

  • Active treatment for cancer Current treatment for inflammatory bowel disease Cirrhosis End-stage renal disease Prior use of a wearable TENS unit for nausea Abdominal surgery within the previous 3 months Pregnancy (self-reported at enrollment) Current carpal tunnel syndrome Any contraindication to use of the EmeTerm device Inflammation, irritation, infection, ulceration, bleeding, open wounds, or other skin conditions near the wrist where the device is applied Presence of metallic implants in the body Head or facial injury within the previous 3 months Known brain tumor, meningitis, or stroke within the previous 3 months Cardiac pacemaker, implanted defibrillator, or other implanted metallic or electronic device History of seizures

Where in United States

  • Ohio State University Wexner Medical CenterColumbus, United StatesContact: Subhankar Chakraborty, MD, Ph.D.Taking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn whether a wearable transcutaneous electrical nerve stimulation (TENS) device called EmeTerm can help reduce nausea in adults who have had nausea for 2 months or longer and who receive care at The Ohio State University. The study will also evaluate whether use of the device affects other symptoms and aspects of wellbeing, including vomiting, abdominal pain, bloating, constipation, appetite, sleep, mood, stress, fatigue, quality of life, and hope. [34_Emeterm...rotocol_v3 | Word]

Read full original descriptionShow less

The main questions it aims to answer are:

Does using the EmeTerm device reduce the average weekly frequency of moderate to severe nausea compared with symptoms during a baseline observation period? [34_Emeterm...rotocol_v3 | Word] Does using the EmeTerm device reduce the duration of nausea, frequency of vomiting, and use of anti-nausea medications, and improve other gastrointestinal symptoms, wellbeing, and quality of life? [34_Emeterm...rotocol_v3 | Word]

This is a single-arm study. Participants will serve as their own comparison by comparing symptoms during device use with symptoms recorded during the baseline period before using the device. [34_Emeterm...rotocol_v3 | Word]

Participants will:

Complete a screening survey and provide electronic informed consent if eligible. [34_Emeterm...rotocol_v3 | Word] Complete baseline questionnaires and record daily gastrointestinal symptoms for a 2-week baseline period. [34_Emeterm...rotocol_v3 | Word] Receive an EmeTerm wearable TENS device and instructions for its use. [34_Emeterm...rotocol_v3 | Word] Use the EmeTerm device for 12 weeks while continuing to record nausea and other gastrointestinal symptoms. [34_Emeterm...rotocol_v3 | Word] Complete weekly and monthly surveys about symptoms, stress, sleep, appetite, fatigue, quality of life, anxiety, depression, autonomic symptoms, device experience, and any adverse events.

The group in the trial

  • EmeTerm Wearable TENS DeviceTreatment being tested

    Participants in this single-arm study will complete a 2-week baseline period during which they record daily gastrointestinal symptoms, including nausea. Participants who complete the baseline phase will receive the EmeTerm wearable transcutaneous electrical nerve stimulation (TENS) device and instructions for its use. During the 12-week treatment period, participants will use the device to help manage nausea while continuing to complete daily symptom diaries and weekly and monthly questionnaires. Study outcomes will compare symptom severity and other patient-reported measures during device use with those recorded during the baseline period.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluating the Effect of a WearIng a TENS-device in NausEa Relief (The WINNER Study)
Plain-language title
Wearable nerve-stimulation band for adults with long-lasting nausea and vomitingGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
22 July 2026